We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Surgical Options for Severe Peritonitis

By HospiMedica staff writers
Posted on 19 Sep 2007
Performing a repeat surgery (relaparotomy) for patients with peritonitis only when clinical improvement is lacking may have some advantages compared with having the repeat procedure routinely scheduled after the operation, according to a new study.

Researchers from the Academic Medical Center (Amsterdam, The Netherlands) conducted a randomized trial comparing the on-demand strategy with the planned relaparotomy strategy following initial emergency surgery for patients with severe secondary peritonitis. More...
The clinical trial was conducted at two academic and five regional teaching hospitals in the Netherlands from November 2001 through February 2005. A total of 232 patients (116 on-demand and 116 planned) were included.

The researchers found that there was no significant difference in death and/or peritonitis-related illness within a 12-month follow-up period. A total of 4% of the on-demand patients had relaparotomy vs. 94% of the planned relaparotomy group. Patients in the on-demand group had shorter median (midpoint) intensive care unit (ICU) stays (7 vs. 11 days) and shorter median hospital stays (27 vs. 35 days). The study was published study in the August 22, 2007 issue of the Journal of the American Medical Association (JAMA).

"This randomized trial found that compared with planned relaparotomy, the on-demand strategy did not result in statistically significant reductions in the primary outcomes of death or major peritonitis-related morbidity but did result in significant reductions in the secondary outcomes of healthcare utilization, including the number of relaparotomies, the use of percutaneous drainage, and hospital and ICU stay,” concluded lead author Oddeke van Ruler, M.D., and colleagues. "Despite a lack of statistically significant improvement in primary clinical outcome, these substantial reductions in healthcare utilization and costs with the on-demand strategy suggest that it may be the preferred strategy.”

Secondary peritonitis has a high rate of death (20-60%), long hospital stays, and a high rate of illness due to the development of sepsis with multiple organ failure. Approximately 12-16% of patients undergoing elective abdominal surgery develop postoperative peritonitis.


Related Links:
Academic Medical Center

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.